University of Antwerp
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.ua.ac.be
Clinical Trials
3
Active:1
Completed:0
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (66.7%)phase_1_2
1 (33.3%)No trials found
News
Bavarian Nordic Initiates First Clinical Trials of Mpox Vaccine in Infants and Pregnant Women
Bavarian Nordic has launched two groundbreaking clinical trials to evaluate the safety and immunogenicity of MVA-BN mpox vaccine in 344 infants aged 4-24 months and 359 pregnant or breastfeeding women.
Study Finds CBD Extract May Reduce Autism Symptoms in Children and Adolescents
New research presented at the European Congress of Psychiatry suggests cannabidiol (CBD) extract improves social responsiveness and reduces disruptive behavior in children with autism spectrum disorder.